KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2019 - 2020)

Aquestive Therapeutics has reported Long-Term Debt Issuances over the past 2 years, most recently at $50.0 million for Q4 2020.

  • Quarterly results put Long-Term Debt Issuances at $50.0 million for Q4 2020, up 171.43% from a year ago — trailing twelve months through Dec 2020 was -$20.0 million (up 71.43% YoY), and the annual figure for FY2023 was $31.1 million, changed.
  • Long-Term Debt Issuances for Q4 2020 was $50.0 million at Aquestive Therapeutics, up from -$70.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for AQST hit a ceiling of $50.0 million in Q4 2020 and a floor of -$70.0 million in Q4 2019.